 SEATTLE--BUSINESS WIRE--Alpine Immune Sciences, Inc. NASDAQ: ALPN, a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the company will release third quarter 2022 financial results on Monday, November 14, 2022, after the close of market. 